Medicared For All Logo

Samuel Myrick MD in Ocala, Florida

Home Florida Ocala

Samuel Myrick MD has Medical Oncology as his primary medical specialty. Their primary office is: 3130 Sw 32nd Ave in Ocala, Florida.

They're a part of the: Ocala Oncology Center Pl medical group which has around 19 members. You can call their office at 352-732-4032 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Florida College Of Medicine and graduated in 1994 (around 30 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Samuel E Myrick MD Office Phone and Directions

Samuel Myrick MD
Ocala Oncology Center Pl
3130 Sw 32nd Ave
Ocala, Florida 34474
352-732-4032


Patient Ratings
Please rate your experience with Samuel Myrick MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 352-732-4032


Enter a starting address:


Healthcare Info for Samuel Myrick MD

Medical School: University Of Florida College Of Medicine
Graduation Year: 1994
The Primary Medical Specialty for Samuel Myrick MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 0941258313
NPI #: 1831180546
NPI Created On: 11/02/2005
NPI Last Updated Listed as: 02/27/2023
Primary Taxonomy Code: 207RX0202X
License Number:
ME90579
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Molina Healthcare of Florida, Inc
  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Mandarin, Chinese.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Nuclear medicine study with ct imaging skull base to mid-thigh
  3. Blood test, comprehensive group of blood chemicals
  4. Carcinoembryonic antigen (cea) protein level
  5. Cyanocobalamin (vitamin b-12) level
  6. Ferritin (blood protein) level
  7. Folic acid level
  8. Iron level
  9. Iron binding capacity
  10. Lactate dehydrogenase (enzyme) level
  11. Magnesium level
  12. Psa (prostate specific antigen) measurement
  13. Blood test, thyroid stimulating hormone (tsh)
  14. Complete blood cell count (red cells, white blood cell, platelets), automated test
  15. Blood test, clotting time
  16. Immunologic analysis for detection of tumor antigen
  17. Flow cytometry technique for dna or cell analysis
  18. Flow cytometry technique for dna or cell analysis
  19. Vaccine for influenza for administration into muscle, 0.5 ml dosage
  20. Hydration infusion into a vein 31 minutes to 1 hour

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727573

Being Disputed:: No

Product Related: No


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727575

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727577

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727579

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727583

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727585

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727587

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727591

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788727589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Medical Oncology Professionals in Ocala

1630 Se 18th St Building 600
Ocala, FL
Florida Cancer Specialists And Research Institute, Llc

Providers in Ocala Oncology Center Pl

1.Tracy Adams

2100 State Ave
Panama City Fl 32405-4587
Ocala Oncology Center Pl
Nurse Practitioner

2.Lilia Aguila

3130 Sw 32nd Ave
Ocala Fl 34474-4445
Ocala Oncology Center Pl
Nurse Practitioner

3.Lilia Aguila

9401 Sw State Rd
Ocala Fl 34481-9651
Ocala Oncology Center Pl
Nurse Practitioner

4.Rama Balaraman Md

9401 Sw State Rd
Ocala Fl 34481-9651
Ocala Oncology Center Pl
Hematology/oncology

5.Maury Berger Md

3130 Sw 32nd Ave
Ocala Fl 34474-4445
Ocala Oncology Center Pl
Hematology/oncology

6.Kelly Carver

2614 Jenks Ave
Panama City Fl 32405-4311
Ocala Oncology Center Pl
Hematology/oncology

View all 19 members of Ocala Oncology Center Pl medical group